Figuera Esparza M, Carballo M, Silva M, Figueredo A, Avilán J
Catedra de Clinica y Terapeutica Medica A, Universidad Central de Venezuela, Hospital Universitario de Caracas, Caracas, Venezuela.
Rev Esp Quimioter. 2006 Sep;19(3):247-51.
We studied the frequency of culture isolation, type of microorganism isolated and local pattern of resistance in 309 adult febrile neutropenic inpatients with hematological neoplasm, who were hospitalized between January 1998 and December 2003, in Caracas University Hospital (Hospital Universitario de Caracas), in Venezuela. There were 576 febrile neutropenic episodes. Organisms were isolated in 41% of 940 cultures. The most common organisms involved were gram-negative bacilli (48%), followed by gram-positive cocci (35.1%), fungal (11.5%) and other agents (5.4%). Coagulase-negative staphylococci (22.4%) and Escherichia coli (13.4%) were the most isolated; 58.5% of 479 agents isolated had an antibiogram; 62.2% of coagulase-negative staphylococci and 23.1% coagulase-positive staphylococci were oxacillin-resistant. We did not find any vancomycin-resistant organisms. The gram-negative antimicrobial sensitivity for imipenem was 96.2%, cefepime 81%, and ceftazidime 57.5%. Tazobactam-piperacillin and sulbactam-cefoperazone were tested in 26% of antibiograms and had activity of 57.1% and 77.5%, respectively. Fungi were not characterized. Betalactamases producing gram-negative bacilli were found. In general, micro-biological identification and local vigilance of antibacterial resistance pattern must be done routinely in these patients, in order to improve empiric therapy guidelines.
我们研究了1998年1月至2003年12月期间在委内瑞拉加拉加斯大学医院住院的309例成年血液肿瘤发热性中性粒细胞减少症住院患者的培养分离频率、分离出的微生物类型和局部耐药模式。共有576次发热性中性粒细胞减少症发作。在940次培养中,41%分离出了微生物。涉及的最常见微生物是革兰氏阴性杆菌(48%),其次是革兰氏阳性球菌(35.1%)、真菌(11.5%)和其他病原体(5.4%)。凝固酶阴性葡萄球菌(22.4%)和大肠杆菌(13.4%)是分离最多的;在分离出的479种病原体中,58.5%有药敏试验结果;62.2%的凝固酶阴性葡萄球菌和23.1%的凝固酶阳性葡萄球菌对苯唑西林耐药。我们未发现任何耐万古霉素的微生物。革兰氏阴性菌对亚胺培南的抗菌敏感性为96.2%,头孢吡肟为81%,头孢他啶为57.5%。在26%的药敏试验中检测了他唑巴坦-哌拉西林和舒巴坦-头孢哌酮,其活性分别为57.1%和77.5%。未对真菌进行鉴定。发现了产β-内酰胺酶的革兰氏阴性杆菌。总体而言,必须对这些患者定期进行微生物鉴定和局部抗菌耐药模式监测,以改进经验性治疗指南。